Cargando…
Parthenolide inhibits the growth of non-small cell lung cancer by targeting epidermal growth factor receptor
BACKGROUND: EGFR tyrosine kinase inhibitors (TKIs) have been developed for the treatment of EGFR mutated NSCLC. Parthenolide, a natural product of parthenolide, which belongs to the sesquiterpene lactone family and has a variety of biological and therapeutic activities, including anti-cancer effects...
Autores principales: | Li, Xiaoling, Huang, Riming, Li, Mingyue, Zhu, Zheng, Chen, Zhiyan, Cui, Liao, Luo, Hui, Luo, Lianxiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7686780/ https://www.ncbi.nlm.nih.gov/pubmed/33292235 http://dx.doi.org/10.1186/s12935-020-01658-1 |
Ejemplares similares
-
Ferroptosis-related gene AKR1C1 predicts the prognosis of non-small cell lung cancer
por: Huang, Fangfang, et al.
Publicado: (2021) -
Fucoxanthin attenuates LPS-induced acute lung injury via inhibition of the TLR4/MyD88 signaling axis
por: Li, Xiaoling, et al.
Publicado: (2020) -
Colocalization of somatostatin receptors and epidermal growth factor receptors in breast cancer cells
por: Watt, Heather L, et al.
Publicado: (2006) -
BAD overexpression inhibits cell growth and induces apoptosis via mitochondrial-dependent pathway in non-small cell lung cancer
por: Jiang, Li, et al.
Publicado: (2013) -
Stress-induced endocytosis and degradation of epidermal growth factor receptor are two independent processes
por: Peng, Ke, et al.
Publicado: (2016)